ATAI
pivotal phase trial designs pivotal study single dose randomization target topline data expected summer pivotal study fixed repeat dose randomization target topline data expected mid compass pathways is currently conducting a program composed of two trials which are to deliver by and | ATAI
Company
Deck date
April 2023
Slide
24 of 30
Similar slides by ATAI
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Presentation
March 2023
Investor Presentation
February 2023
Related slides by other companies
Investor Day
March 2022
Investor Presentation
December 2024
Investor Presentation
December 2024
Investor Presentation
November 2024
Other recent decks by ATAI
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io